Pfizer withdrew its sickle cell disease treatment Oxbryta. Meanwhile, Senators introduce new bill to fortify health-care ...

Pfizer withdrew Oxbryta (voxelotor), a conditionally approved oral therapy for SCD, saying its benefits don't outweigh risks.

Healthcare professionals have been urged to stop supplying Oxbryta “immediately” after new data revealed “an unfavourable imbalance” of “fatal events” and “acute painful crises” in patients on the ...

Pfizer has divested a $3.3 billion stake in Haleon, reducing its holding in the British consumer healthcare company.

A Johns Hopkins analysis commissioned by STAT shows that the rate of postpartum sterilization is significantly higher in ...

Pfizer recalled Oxbryta and ended clinical trials over safety concerns, but sickle cell advocates are warning that stopping the drug abruptly could be dangerous.

The questions of drugs, real and spurious, has come up in the healthcare sector this week, with reports of drugs not meeting ...

About 25 people were feared dead in Thailand on Tuesday when a school bus carrying students and teachers on a field trip caught fire on the outskirts of the capital Bangkok, with 16 passengers ...

The Barcelona-based startup Sequentia Biotech has raised €10 million ($11 million) in a Series A round to finance the development of its omics-based technology for use in biomedicine, agritech and ...

The attack, which ended shortly after it began, capped a chaotic 24-hour period that began with Israel’s invading of Lebanon in pursuit of Hezbollah. Iran fired a barrage of ballistic missiles ...

Rescue workers searched for survivors in the mountains of western North Carolina on Tuesday, trying to contact and deliver aid to hundreds of people cut off by washed-out roads, felled power lines ...